NCT00407732View on ClinicalTrials.gov

Overcoming Psychiatric Barriers to the Treatment of Hepatitis C

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

October 31, 2011

Conditions
Hepatitis CSubstance Use DisordersMental Disorder
Interventions
BEHAVIORAL

psychosocial intervention

motivational enhancing case management intervention

Trial Locations (1)

27599

Unversity of North Carolina, Chapel Hill

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT00407732 - Overcoming Psychiatric Barriers to the Treatment of Hepatitis C | Biotech Hunter | Biotech Hunter